Drug Mechanism of Action Two Flashcards
What is the name of the endogenous binding site?
The orthosteric site
What is an alternative name to the orthosteric site?
The endogenous agonist binding site
Is the endogenous orthosteric binding site the only binding site?
No there is also the allosteric site.
What binds to the allosteric site?
Allosteric modulators
When do allosteric interactions occur?
Allosteric interaction occurs between the othrosteric site and any additional conformationally linked site when both sites are occupied by ligands.
What is an allosteric modulator?
Ligands that bind to an allosteric site on the GPRC to modulate the binding and or signalling properties of the othrosteric site
What does the allosteric modulator manipulate?
Affinity and Efficacy.
What is the difference between affinity, Efficacy and potency?
Affinity describes the ability of a ligand to bind to a receptor.
Efficacy is defined by Emax, which is the maximal response able to be produced by a ligand. It also defines if a ligand is an agonist, inverse agonist or antagonist.
Potency is described by EC50, the concentration of drug required to produce 50% of the maximal response. The lower the EC50 the more potent the drug.
What three properties can an allosteric modulator manipulate? and what does this do to the concentration response curve?
Affinity (same Emax but curve is left shift)
Efficacy (increased Emax)
Agonism (Curve shifts upwards)
How can an allosteric modulator alter affinity?
It can increase ligand association rate or decrease ligand dissociation rate (this is more common)
Allosteric inhibition can arise from the opposite of this.
How do allosteric modulators change efficacy?
Allosteric modulators have been found to change efficacy of a ligand regardless of affinity.
i.e Emax increases, but the concentration of agonist to achieve ti remains the same, so the y values increase but x remain remain.
What sort of antagonist would an allosteric modulator be?
Non-competitive antagonist
Describe some of the complicated effects allosteric modulators can have
They can increase affinity and decrease efficacy.
What is the ceiling effect, and how does it influence the maximal capacity of allosteric non-competitive antagonism vs reversible competitive antagonism?
Reversible competitive antagonism has no ceiling effect and you can increase the level of agonist and the level of antagonist will also need increasing to maintain the effects. i.e it can right shift infinitely.
Allosteric antagonist have limited right and left shifts (depending on effects) i.e it can only have so much effect….
Why does the ceiling effect exist?
Simple, allosteric modulators do not compete with other ligands therefore once they have bound all receptors their effects are measured in full - as to work ligand must be present.
Why would we want to target an allosteric site rather than an othrosteric site?
The allosteric site is more likely to be highly selective therefore it is easier to bind to a specific receptor. I.e seratonin has 6 orthosteric receptors. Each of its receptors are similar in order to bind seratonin. However each receptor will have its own allosteric site. Thus a specific receptor can be targeted.
Also there are very few endogenous allosteric modulators.
Whats an example of a non-GPCR with an allosteric site?
Ligand gated ion channels.
I.e Benzodiapines target allosteric sites of ligand gated ion channels.
What therapeutic opportunity does an allosteric binding site provide?
Provide another level of selectivity
May only act when endogenous ligand is present, therefore greater spatial and temporal drug
Ceiling effect of non-competitive antagonist
Stimulatory or Inhibitory effects can be caused by drugs. Naming the major groups of drug targets, list if it is possible to produce either effect?
Receptors - drugs can inhibit or activate
Ion Channels - Drugs can only Inhibit
Carrier Molecules (Transporters) - drugs can only inhibit
enzymes - drugs can only inhibit
Why do Enzymes, transporters as drug targets, only inhibit?
The drug in these instances binds to the orthosteric site, therefore preventing the binding of the endogenous ligand = inhibition of action